inixaciclib (NUV-422) / Nuvation Bio  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
inixaciclib (NUV-422) / Nuvation Bio
NCT05191017: Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Withdrawn
1b/2
0
US
NUV-422, Enzalutamide, Xtandi
Nuvation Bio Inc.
Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration Resistant Prostatic Cancer, Castration Resistant Prostatic Neoplasms
01/25
07/26
NCT04541225: Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Terminated
1/2
74
US
NUV-422
Nuvation Bio Inc.
Glioma, Glioma, Malignant, Glioma, Mixed, Glial Cell Tumors, Breast Cancer, Breast Carcinoma, Cancer of Breast, Cancer of the Breast, Breast Tumor, Malignant Tumor of Breast, Advanced Breast Cancer, Advanced Breast Carcinoma, Metastatic Breast Cancer, Metastatic Breast Carcinoma, Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration-resistant Prostate Cancer, Castration Resistant Prostatic Neoplasms, Glioblastoma, Recurrent Glioblastoma
08/22
08/22
NCT05191004: Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

Withdrawn
1/2
0
US
NUV-422, Fulvestrant, Faslodex
Nuvation Bio Inc.
Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Breast Carcinoma, Cancer of the Breast, Cancer of Breast, Malignant Tumor of Breast, Breast Tumor
06/25
09/26

Download Options